Biomedical data company Seven Bridges Genomics has launched a network that will provide more than 5 million patient datasets for use in clinical trials involving precision medicine.

Seven Bridges’ Unified Patient Network (UPN) will function as a collaborative group of nonprofit academic health centers and other health systems taking part in clinical research for precision medicine. UPN’s database will eventually contain de-identified clinical and genome-related data drawn from participants in trials conducted by network members.

UPN will charge biopharmas to access its data and use them in their own clinical research, with some of the funds going back to support research efforts of health systems participating in the network.

Many diseases and therapeutic areas will be covered by the network, including rare complex neurodegenerative diseases, cancer and cardiology, psychiatric and autoimmune diseases/disorders and common diseases like diabetes.